Gregory J Madden1, David Kalman. 1. Department of Applied Behavioral Science, University of Kansas, 1000 Sunnyside Ave, Lawrence, KS 66045, USA. gmadden@ku.edu
Abstract
INTRODUCTION: The biobehavioral mechanism(s) mediating bupropion's efficacy are not well understood. Behavioral economic measures such as demand curves have proven useful in investigations of the reinforcing effects of drugs of abuse. Behavioral economic measures may also be used to measure the effect of pharmacotherapies on the reinforcing effects of drugs of abuse. METHODS: The effects of bupropion on simulated demand for cigarettes were investigated in a placebo-controlled double-blind clinical trial. Participants reported the number of cigarettes they would purchase and consume in a single day at a range of prices. The effects of medication on the subjective effects of smoking were also explored. RESULTS:Demand for cigarettes was well described by an exponential demand equation. Bupropion did not significantly decrease the maximum number of cigarettes that participants said they would smoke in a single day nor did it significantly alter the relation between price per cigarette and demand. Baseline demand elasticity did not predict smoking cessation, but changes in elasticity following 1 week of treatment did. Medication group had no effect on any subjective effects of smoking. DISCUSSION: Bupropion had no significant effects on demand for cigarettes. The exponential demand equation, recently introduced in behavioral economics, proved amenable to human simulated demand and might be usefully employed in other pharmacotherapy studies as it provides a potentially useful measure of changes in the essential value of the drug as a reinforcer. Such changes may be useful in predicting the efficacy of medications designed to reduce drug consumption.
RCT Entities:
INTRODUCTION: The biobehavioral mechanism(s) mediating bupropion's efficacy are not well understood. Behavioral economic measures such as demand curves have proven useful in investigations of the reinforcing effects of drugs of abuse. Behavioral economic measures may also be used to measure the effect of pharmacotherapies on the reinforcing effects of drugs of abuse. METHODS: The effects of bupropion on simulated demand for cigarettes were investigated in a placebo-controlled double-blind clinical trial. Participants reported the number of cigarettes they would purchase and consume in a single day at a range of prices. The effects of medication on the subjective effects of smoking were also explored. RESULTS: Demand for cigarettes was well described by an exponential demand equation. Bupropion did not significantly decrease the maximum number of cigarettes that participants said they would smoke in a single day nor did it significantly alter the relation between price per cigarette and demand. Baseline demand elasticity did not predict smoking cessation, but changes in elasticity following 1 week of treatment did. Medication group had no effect on any subjective effects of smoking. DISCUSSION: Bupropion had no significant effects on demand for cigarettes. The exponential demand equation, recently introduced in behavioral economics, proved amenable to human simulated demand and might be usefully employed in other pharmacotherapy studies as it provides a potentially useful measure of changes in the essential value of the drug as a reinforcer. Such changes may be useful in predicting the efficacy of medications designed to reduce drug consumption.
Authors: D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker Journal: N Engl J Med Date: 1999-03-04 Impact factor: 91.245
Authors: Margaret Rukstalis; Christopher Jepson; Andrew Strasser; Kevin G Lynch; Kenneth Perkins; Freda Patterson; Caryn Lerman Journal: Psychopharmacology (Berl) Date: 2005-01-29 Impact factor: 4.530
Authors: Matt Field; Mary Santarcangelo; Harry Sumnall; Andrew Goudie; Jon Cole Journal: Psychopharmacology (Berl) Date: 2006-04-12 Impact factor: 4.530
Authors: James MacKillop; Courtney L Brown; Monika K Stojek; Cara M Murphy; Lawrence Sweet; Ray S Niaura Journal: Nicotine Tob Res Date: 2012-03-13 Impact factor: 4.244
Authors: Tyler D Nighbor; Anthony J Barrows; Janice Y Bunn; Michael J DeSarno; Anthony C Oliver; Sulamunn R M Coleman; Danielle R Davis; Joanna M Streck; Ellaina N Reed; Derek D Reed; Stephen T Higgins Journal: Prev Med Date: 2020-07-24 Impact factor: 4.018
Authors: Bryan W Heckman; Geoffrey T Fong; Ron Borland; Sara Hitchman; Richard J O'Connor; Warren K Bickel; Jeffrey S Stein; Hua-Hie Yong; Georges J Nahhas; Derek A Pope; Ce Shang; Kai-Wen Cheng; David T Levy; K Michael Cummings Journal: Addiction Date: 2019-02-15 Impact factor: 6.526
Authors: Cara M Murphy; James MacKillop; Rosemarie A Martin; Jennifer W Tidey; Suzanne M Colby; Damaris J Rohsenow Journal: Psychopharmacology (Berl) Date: 2017-05-13 Impact factor: 4.530
Authors: Tyler D Nighbor; Sulamunn R M Coleman; Janice Y Bunn; Michael J DeSarno; Adam L Morehead; Katherine J Tang; Diana R Keith; Shirley T Plucinski; Allison N Kurti; Ivori Zvorsky; Stephen T Higgins Journal: Exp Clin Psychopharmacol Date: 2020-02-27 Impact factor: 3.157
Authors: Bryan W Heckman; K Michael Cummings; Georges J Nahas; Marc C Willemsen; Richard J O'Connor; Ron Borland; Alexander A Hirsch; Warren K Bickel; Matthew J Carpenter Journal: Nicotine Tob Res Date: 2019-05-21 Impact factor: 4.244